Search Medical Condition
Please enter condition
Please choose location from dropdown

Monastir, Tunisia Clinical Trials

A listing of Monastir, Tunisia clinical trials actively recruiting patients volunteers.

RESULTS

Found (17) clinical trials

Global Non-interventional Heart Failure Disease Registry

The clinical characteristics, initial presentation, management, and outcomes of patients hospitalized with new-onset (first diagnosis) heart failure (HF) or decompensation of chronic HF are poorly understood worldwide. REPORT-HF is a global, prospective, and observational HF disease registry designed to characterize patient trajectories longitudinally during and following an index hospitalization for ...

Phase N/A

10.74 miles

Learn More »

Efficacy and Safety Study of I10E in Treatment of Patients With CIDP

Primary objective: To assess the efficacy of I10E in improving the disability of patients with CIDP. Secondary objective: To assess the safety of I10E in patients with CIDP.

Phase

10.74 miles

Learn More »

Efficacy and Safety Study of I10E in the Maintenance Treatment of Patients With CIDP: Extension of PRISM Study I10E-1302

Primary objective: To assess the efficacy of I10E administered at a reduced maintenance dose in sustaining CIDP response after an initial 6-month treatment in PRISM study. (I10E-1302). Secondary objective: To assess the safety of I10E in this patient population.

Phase

10.74 miles

Learn More »

Study to Compare the Efficacy of Pristinamycin (Pyostacine ) Versus Amoxicillin in the Treatment of Acute Community Acquired Pneumonia

The total study duration for each patient is 1 month with a treatment period of 7 to 9 days and a follow-up period of 21 to 23 days.

Phase

10.74 miles

Learn More »

The International Polycap Study 3 (TIPS-3)

Cardiovascular disease (CVD), cancers and osteoporosis collectively make up the largest disease burden globally. CVD is the major cause of death and disability and affects about half of the population over their lifetimes. Cancers are a leading cause of death and it accounts for 13.0% of all deaths. The commonest ...

Phase

3214.14 miles

Learn More »

Digoxin Short Term Treatment Assessment Randomized Trial in AHF

AHFS management is challenging given the heterogeniety of the patient population, absence of a universally accepted definition, incomplete understanding of its pathophysiology, and lack of evidence based guidelines. The majority of patients appear to respond well to initial therapies consisting of loop diuretics and vasoactive agents. however, this treatments failed ...

Phase

0.97 miles

Learn More »

NSAIDs Versus Paracetamol Versus Paracetamol + NSAIDs in Traumatic Pain Management

Paracetamol, NSAIDs, or a combination of the two molecules are usually prescribed. Patients even use these medications without a prescription. It is not known, however, whether or not NSAIDs have an additional value relative to paracetamol for the treatment of pain. This is a prospective, randomized, double-blind, controlled study carried ...

Phase

0.97 miles

Learn More »

Systolic Time Intervals in the Diagnosis of Heart Failure in Emergency Departement

AHF is a common cause for dyspnea, but still hard to diagnose. in emergency departements, physicians dispose of a variety of techniques helping them to identify patients with acute onset dyspnea due to cardiac causes and allowing them to initiate the appropriate therapeutics. techniques such as the N type brain ...

Phase N/A

0.97 miles

Learn More »

IV NSAI Versus Nebulized Morphine Analgesia for First-line Renal Colic

Renal colic are a frequent cause of consultation in the emergency departement (ED). They count for approximatively 20% of patients presenting to the ED with severe acute onset abdominal pain. For acute treatment of renal colics (RC), guidelines recommend the use of intravenous (IV) non-steroidal anti-inflammatory (NSAI) drugs in association ...

Phase

0.97 miles

Learn More »

Short Antibiotic Treatment Versus Duration Guided by Markers of Inflammation in the Treatment of AECOPD

This study is a randomized prospective double-blind, accomplished with sealed envelopes ,with three parallel groups : Group A: Short treatment: 1 tablet Levofloxacin 500mg / day hang two days completed by 1 tablet Placebo Levofloxacin 500mg / day for 5 days. Group B: Short Treatment control : 1 tablet Levofloxacin ...

Phase

0.97 miles

Learn More »